Get the Stockscreener App
37.58
0.03%
0.010
Surmodics Inc stock is traded at $37.58, with a volume of 26,709.
It is up +0.03% in the last 24 hours and down -2.19% over the past month.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
See More
Previous Close:
$37.57
Open:
$37.48
24h Volume:
26,709
Relative Volume:
0.19
Market Cap:
$537.01M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
-22.78
EPS:
-1.65
Net Cash Flow:
$9.86M
1W Performance:
+0.19%
1M Performance:
-2.19%
6M Performance:
+15.67%
1Y Performance:
+21.03%
1-Day Range:
$37.14
$37.79
1-Week Range:
$37.14
$37.87
52-Week Range:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
Surmodics reports high success in limb ischemia study By Investing.com - Investing.com South Africa
Surmodics reports high success in limb ischemia study - Investing.com India
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - StockTitan
When (SRDX) Moves Investors should Listen - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.com - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.com - MarketBeat
Medical Coatings Market to Grow by USD 5.07 Billion from 2024-2028, Driven by Geriatric Population Growth and AI-Redefining the Market LandscapeTechnavio - Yahoo Finance Australia
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Millennium Management LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Surmodics, Inc. to Post FY2025 Earnings of $0.13 Per Share, Zacks Research Forecasts (NASDAQ:SRDX) - MarketBeat
AQR Capital Management LLC Reduces Holdings in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Trend Tracker for (SRDX) - Stock Traders Daily
Algert Global LLC Makes New $577,000 Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
SRDX Stock Down Despite FDA Clearance for Pounce XL System - MSN
Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research - GlobeNewswire Inc.
FDA clears Surmodics’ Pounce XL thrombectomy system - Mass Device
FDA clears Surmodics' expanded thrombectomy system - Investing.com India
Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter - BioSpace
Water Island Capital LLC Makes New $1.16 Million Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Medical Grade Coatings Market Size Research Report 2032 - WICZ
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Disciplined Growth Investors Inc. MN - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Short Interest Down 25.3% in September - MarketBeat
(SRDX) Trading Advice - Stock Traders Daily
Solar Stock Under Rs 50: Microcap Company Secures Rs 189 Crore Order, Stock Hits Upper Circuit – Complete Details Inside! - Dalal Street Investment Journal
Views of Wall Street’s Leading Experts on Summit Materials Inc - SETE News
Here's why Sumit Gupta is bullish on diagnostic sector - The Economic Times
Sagefield Capital LP Takes $2.35 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Summit Materials, Inc. (NYSE:SUM) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Scilex (NASDAQ:SCLX) and Prime Medicine (NYSE:PRME) Critical Analysis - Defense World
Dimensional Fund Advisors LP Cuts Position in Sterling Infrastructure, Inc. (NASDAQ:STRL) - Defense World
Dimensional Fund Advisors LP Cuts Stock Holdings in Summit Materials, Inc. (NYSE:SUM) - Defense World
Renaissance Technologies LLC Acquires 28,990 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Sterling Construction stock soars to all-time high of $137.93 - Investing.com
Gardner Lewis Asset Management L P Buys New Shares in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
(SRDX) Investment Report - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Trium Capital LLP Takes $1.41 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
SurModics (SRDX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Down -5.46% in 4 Weeks, Here's Why SurModics (SRDX) Looks Ripe for a Turnaround - Yahoo Finance
Wolverine Asset Management LLC Buys Shares of 25,966 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Research Coverage Started at StockNews.com - MarketBeat
Versor Investments LP Makes New Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Sees Significant Decrease in Short Interest - MarketBeat
Bailard Inc. Makes New Investment in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Nisa Investment Advisors LLC - Defense World
Nisa Investment Advisors LLC Has $2.88 Million Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by California State Teachers Retirement System - Defense World
Analysts Issue Forecasts for Surmodics, Inc.'s FY2024 Earnings (NASDAQ:SRDX) - MarketBeat
Surmodics, Inc. Expected to Earn FY2024 Earnings of ($0.47) Per Share (NASDAQ:SRDX) - Defense World
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surmodics Inc Stock (SRDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Maharaj Gary R | President & CEO |
Aug 21 '24 |
Option Exercise |
33.20 |
61,017 |
2,025,764 |
253,151 |
| OLSON CHARLES W | SVP, Medical Device Coatings |
Aug 16 '24 |
Option Exercise |
33.20 |
18,447 |
612,440 |
70,698 |
| Arens Timothy J. | Chief Financial Officer |
Aug 16 '24 |
Option Exercise |
33.20 |
18,447 |
612,440 |
94,088 |
| BEDOYA JOSE H | Director |
Feb 08 '24 |
Option Exercise |
23.95 |
3,932 |
94,171 |
30,108 |
| KNIGHT SUSAN E | Director |
Feb 05 '24 |
Option Exercise |
23.95 |
3,932 |
94,171 |
36,267 |
| DANTZKER DAVID | Director |
Jan 19 '24 |
Option Exercise |
23.95 |
3,932 |
94,171 |
40,094 |
| KALICH RONALD B SR | Director |
Dec 27 '23 |
Option Exercise |
23.95 |
3,932 |
94,171 |
38,529 |
| Stich Joseph J. | SVP HR and IVD |
Nov 15 '23 |
Option Exercise |
23.95 |
17,121 |
410,048 |
72,433 |
| OLSON CHARLES W | SVP, Medical Device Coatings |
Nov 15 '23 |
Option Exercise |
23.95 |
12,841 |
307,542 |
58,937 |
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):